Final Trades: Verizon, Abbvie, Gilead Sciences and Arch Capital Group

Jenny Harrington, Gilman Hill Asset Management CEO, Jim Lebenthal, chief equity strategist at Cerity Partners, Joe Terranova, senior managing director at Virtus Investment Partners, and Rob Sechan, managing partner at NewEdge Wealth, join CNBC's Halftime Report' to give their top picks to watch for the second half.